IFNA2 and cancer: We found that IFN-α potentiates the antiproliferative and pro-apoptotic properties of azacitidine and romidepsin in vitro and it is essential for triggering cell death with immunogenic features, ultimately improving dendritic cell (DC) phagocytosis of drug-treated cancer cells.